Cohort in Qianwan New District, Ningbo
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRenJi Hospital
About this trial
Our objective is to carry out research on prevention and control of noncommunicable chronic diseases, and establish a risk prediction mechanism for chronic diseases to promote early detection, early diagnosis and early treatment of chronic diseases in natural population in Qianwan District of Ningbo, significantly reduce medical costs and extend population life span.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
1) Local permanent residents aged 18 and above (including residents with household registration, or residents without household registration but with a permanent job);
2) No serious physical disability, can communicate normally;
3) Participate voluntarily and sign informed consent.
Disqualifiers
1) Temporary resident and floating population;
2) There are serious health conditions unable to participate in the survey;
3) Those who are unwilling to accept the follow-up inspection of the project.
Trial population
Relying on the manufacturing factories gathered around Hangzhou Bay Hospital, a relatively stable cohort of participants was provided. According to the entry criteria, eligible subjects were selected to be included in the Hangzhou Bay natural population cohort.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
death
Mortality of all-cause disease were calculated by age, gender and area compared by different health management mode.
Time frame
4 years2
incidence of cardio-cerebrovascular diseases
Incidence of Cardiovascular and Cerebrovascular diseases were calculated by age, gender and area compared by different health management mode.
Time frame
4 years3
incidence of other non-communicable chronic diseases
Incidence of other non-communicable chronic diseases were calculated by age, gender and area compared by different health management mode.
Time frame
4 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
RenJi Hospital
Lead sponsor
Ningbo Hangzhou Bay Hospital
Collaborator
Source ClinicalTrials.gov